Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
Jay T Guevarra, Robert Hiensch, Andrew W Varga, David M Rapoport Division of Pulmonary, Critical Care, and Sleep Medicine, Mount Sinai Integrative Sleep Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USACorrespondence: Jay T GuevarraDivision of Pulmonary, Critical Care, and Sle...
Saved in:
Main Authors: | Guevarra JT, Hiensch R, Varga AW, Rapoport DM |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/9e56c7d5904649659b556f6c4e2f56f7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on the treatment of narcolepsy: clinical efficacy of pitolisant
by: Calik MW
Published: (2017) -
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
by: Vellieux G, et al.
Published: (2021) -
Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects
by: Sahni AS, et al.
Published: (2019) -
Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHAD
by: Wang YG, et al.
Published: (2017) -
Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
by: Abad VC
Published: (2021)